Sg Americas Securities, LLC Absci Corp Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$3.41 - $5.74 $38,028 - $64,012	11,152 New	11,152 $63,000
Q1 2023 Apr 28, 2023	SELL	$1.58 - $3.41 $5,000 - $10,792	-3,165 Reduced 13.88%	19,640 $34,000
Q4 2022 Feb 02, 2023	BUY	$2.0 - $3.58 $11,606 - $20,774	5,803 Added 34.13%	22,805 $48,000
Q3 2022 Oct 31, 2022	SELL	$2.95 - $4.83 $6,215 - $10,176	-2,107 Reduced 11.03%	17,002 $53,000
Q2 2022 Jul 29, 2022	BUY	$3.13 - $8.83 $59,811 - $168,732	19,109 New	19,109 $63,000

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $278M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.